• 
  Antoine Drouillard, Anne-Marie Bouvier, Olayidé Boussari, Gaëlle Romain, Sylvain Manfredi, et al.. Net survival in recurrence-free colon cancer patients. Cancer Epidemiology, 2019, 61, pp.124 - 128. ⟨10.1016/j.canep.2019.06.001⟩. ⟨hal-03485853⟩
• 
  Fabrice Carrat, Hélène Fontaine, Céline Dorival, Mélanie Simony, Alpha Diallo, et al.. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study. The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩. ⟨hal-02050395⟩
• 
  Adrien Guilloteau, Michal Abrahamowicz, Olayide Boussari, Valérie Jooste, Thomas Aparicio, et al.. Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer. BMC Medical Research Methodology, 2021, 21 (1), pp.14. ⟨10.1186/s12874-020-01202-9⟩. ⟨inserm-03314999⟩
• 
  Thomas Aparicio, Francois Ghiringhelli, Valérie Boige, Karine Le Malicot, Julien Taieb, et al.. Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). Journal of Clinical Oncology, 2018, 36 (7), pp.674 - 681. ⟨10.1200/JCO.2017.75.2931⟩. ⟨hal-01728824⟩
• 
  Alexis Mathian, Suzanne Mouries-Martin, Karim Dorgham, Herve Devilliers, Laura Barnabei, et al.. Monitoring disease activity in systemic lupus erythematosus with single-molecule array digital ELISA quantification of serum interferon-α. Arthritis & rheumatology, 2019, ⟨10.1002/art.40792⟩. ⟨hal-01952505⟩

16

128